Starlight Cardiovascular Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Employees
  • 8

Employees

  • Latest Deal Type
  • Early Stage VC

  • Investors
  • 8

Starlight Cardiovascular General Information

Description

Developer of a medical device intended to treat babies born with congenital heart disease. The company's devices are regenerative, infection resistant and have applications in cardiovascular patches, enabling healthcare professionals to improve the clinical outcomes of substitute conduit arteries in infants and children and reduce the risk of repetitive surgeries.

Contact Information

Website
www.starlightcardio.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 9710 Scranton Road
  • Suite 100
  • San Diego, CA 92121
  • United States
+1 (603)
Primary Industry
Therapeutic Devices
Vertical(s)
Manufacturing, Digital Health, HealthTech
Corporate Office
  • 9710 Scranton Road
  • Suite 100
  • San Diego, CA 92121
  • United States
+1 (603)

Starlight Cardiovascular Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Starlight Cardiovascular Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Early Stage VC 09-Aug-2024 Completed Generating Revenue
7. Grant 01-May-2024 Completed Generating Revenue
6. Grant 22-Mar-2023 Completed Generating Revenue
5. Early Stage VC (Series A) 29-Nov-2022 Completed Startup
4. Accelerator/Incubator 16-Aug-2021 Completed Startup
3. Grant 06-Aug-2021 Completed Startup
2. Grant 30-May-2021 $598K $25K Completed Startup
1. Accelerator/Incubator 26-Mar-2021 $25K $25K Completed Startup
To view Starlight Cardiovascular’s complete valuation and funding history, request access »

Starlight Cardiovascular Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series A-1
Series A
To view Starlight Cardiovascular’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Starlight Cardiovascular Patents

  • 21

    Total Documents Applications and Grants

  • Total Patents Families

  • 3

    Granted

  • 13

    Pending

  • Expiring in next 12 mo

Starlight Cardiovascular Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
JP-2026509987-A Device and method for delivering non-balloon type expansion implants Pending 20-Mar-2023
EP-4683822-A1 Devices and methods for delivering non-balloon expandable implants Pending 20-Mar-2023
WO-2024197032-A1 Devices and methods for delivering non-balloon expandable implants Inactive 20-Mar-2023
EP-4539790-A2 Variable diameter stents Pending 16-Jun-2022
EP-4539790-A4 Variable diameter stents Pending 16-Jun-2022 A61F2/915
To view Starlight Cardiovascular’s complete patent history, request access »

Starlight Cardiovascular Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Starlight Cardiovascular Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds
National Heart, Lung, and Blood Institute Government
Bird B. Family Office Minority
Catalytic Impact Foundation Not-For-Profit Venture Capital
Impact Assets Impact Investing Minority
The Consortium for Technology & Innovation in Pediatrics Accelerator/Incubator
You’re viewing 5 of 8 investors. Get the full list »

Ready to get started?

Request a free trial

Starlight Cardiovascular FAQs

  • When was Starlight Cardiovascular founded?

    Starlight Cardiovascular was founded in 2020.

  • Where is Starlight Cardiovascular headquartered?

    Starlight Cardiovascular is headquartered in San Diego, CA.

  • What is the size of Starlight Cardiovascular?

    Starlight Cardiovascular has 8 total employees.

  • What industry is Starlight Cardiovascular in?

    Starlight Cardiovascular’s primary industry is Therapeutic Devices.

  • Is Starlight Cardiovascular a private or public company?

    Starlight Cardiovascular is a Private company.

  • What is Starlight Cardiovascular’s current revenue?

    The current revenue for Starlight Cardiovascular is .

  • How much funding has Starlight Cardiovascular raised over time?

    Starlight Cardiovascular has raised $9.5M.

  • Who are Starlight Cardiovascular’s investors?

    National Heart, Lung, and Blood Institute, Bird B., Catalytic Impact Foundation, Impact Assets, and The Consortium for Technology & Innovation in Pediatrics are 5 of 8 investors who have invested in Starlight Cardiovascular.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process